Mutational burden of hepatoblastomas: a role for the CX3CL1/CX3CR1 chemokine signaling pathway
Talita Ferreira Marques Aguiar,
Maria Prates Rivas,
Juliana Sobral de Barros,
Anne Caroline Barbosa,
Gustavo Ribeiro Fernandes,
Silvia Regina Caminada de Toledo,
Maria Lúcia de Pinho Apezzato,
Dirce Maria Carraro,
Cecilia Maria Lima da Costa,
Isabela Werneck da Cunha,
Stephen Frederick Sarabia,
Ana Cristina Victorino Krepischi
Posted 22 Feb 2019
bioRxiv DOI: 10.1101/555466
Posted 22 Feb 2019
Hepatoblastoma is an embryonal liver tumor supposed to arise from the impairment of hepatocyte differentiation during embryogenesis. CTNNB1 is the only recurrently mutated gene. In this study, we investigated by exome sequencing the burden of somatic mutations in a cohort of 10 hepatoblastomas, including a congenital case. Our data disclosed a low mutational background with only three recurrently mutated genes: CTNNB1 and two candidates, CX3CL1 and CEP164. The major finding was a recurrent mutation (A235G) identified in two hepatoblastomas at the CX3CL1 gene; evaluation of RNA and protein expression revealed up-regulation of CX3CL1 in tumors. The analysis was replicated in two independents cohorts, substantiating that an activation of the CX3CL1/CX3CR1 pathway occurs in hepatoblastomas, with a predominance of these proteins in the cytoplasm of tumor cells. These proteins were not detected in the infiltrated lymphocytes of inflammatory regions of the tumors, in which they should be expressed in normal conditions, whereas necrotic regions exhibited negative tumor cells, but strongly positive infiltrated lymphocytes. Our data suggested that CX3CL1/CX3CR1 upregulation may be a common feature of hepatoblastomas. In addition, three mutational signatures were identified in hepatoblastomas, two of them with predominance of either the COSMIC signatures 1 and 6, found in all cancer types, or the COSMIC signature 29, related only with tobacco chewing habit; a third novel mutational signature presented an unspecific pattern. Overall, we present here evidence that CX3CL1/CX3CR1 chemokine signaling pathway is involved with hepatoblastoma tumorigenesis or progression, besides reporting a novel mutational signature specific to a hepatoblastoma subset.
- Downloaded 377 times
- Download rankings, all-time:
- Site-wide: 44,545 out of 92,180
- In cancer biology: 1,409 out of 3,261
- Year to date:
- Site-wide: 22,533 out of 92,180
- Since beginning of last month:
- Site-wide: 37,608 out of 92,180
Downloads over time
Distribution of downloads per paper, site-wide
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!